| 0 |
FEELING OF RELAXATION |
1 |
0.0015 |
| 1 |
NONINFECTIVE ENCEPHALITIS |
1 |
0.0014 |
| 2 |
ALTERED VISUAL DEPTH PERCEPTION |
1 |
0.0012 |
| 3 |
JC POLYOMAVIRUS TEST POSITIVE |
1 |
0.0009 |
| 4 |
HEART RATE DECREASED |
28 |
0.0008 |
| 5 |
CUTANEOUS T-CELL LYMPHOMA |
1 |
0.0008 |
| 6 |
CARBON DIOXIDE INCREASED |
1 |
0.0007 |
| 7 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
3 |
0.0007 |
| 8 |
LEUKAEMIA RECURRENT |
1 |
0.0006 |
| 9 |
MASTECTOMY |
1 |
0.0006 |
| 10 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 11 |
OCULAR HYPERTENSION |
1 |
0.0005 |
| 12 |
WALKING DISABILITY |
1 |
0.0005 |
| 13 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 14 |
WRONG DOSE |
1 |
0.0004 |
| 15 |
MACULAR OEDEMA |
2 |
0.0004 |
| 16 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 17 |
REGURGITATION |
1 |
0.0003 |
| 18 |
LYMPHOCYTE COUNT DECREASED |
5 |
0.0003 |
| 19 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 20 |
FOOD ALLERGY |
2 |
0.0003 |
| 21 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 22 |
OPTIC NEURITIS |
2 |
0.0002 |
| 23 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 24 |
ASTHENOPIA |
1 |
0.0002 |
| 25 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 26 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 27 |
CATARACT OPERATION |
1 |
0.0002 |
| 28 |
MULTIPLE SCLEROSIS RELAPSE |
11 |
0.0002 |
| 29 |
FORMICATION |
1 |
0.0001 |
| 30 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 31 |
PAROSMIA |
1 |
0.0001 |
| 32 |
APHTHOUS ULCER |
1 |
0.0001 |
| 33 |
HEMIPARESIS |
2 |
0.0001 |
| 34 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 35 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 36 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 37 |
FEELING JITTERY |
2 |
0.0001 |
| 38 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 39 |
COELIAC DISEASE |
1 |
0.0001 |
| 40 |
THERAPY CHANGE |
1 |
0.0001 |
| 41 |
BLADDER DISORDER |
1 |
0.0001 |
| 42 |
TASTE DISORDER |
2 |
0.0001 |
| 43 |
DRY THROAT |
1 |
0.0001 |
| 44 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 45 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 46 |
MALNUTRITION |
1 |
0.0001 |
| 47 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 48 |
MULTIPLE SCLEROSIS |
4 |
0.0001 |
| 49 |
POLYNEUROPATHY |
1 |
0.0001 |
| 50 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 51 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 52 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 53 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 54 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 55 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 56 |
BLINDNESS |
3 |
0.0001 |
| 57 |
HEPATIC ENZYME INCREASED |
5 |
0.0001 |
| 58 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 59 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 60 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 61 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 62 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 63 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 64 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 65 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 66 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 67 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 68 |
SOMNOLENCE |
12 |
0.0001 |
| 69 |
CANDIDA INFECTION |
1 |
0.0001 |
| 70 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 71 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 72 |
PHOTOPHOBIA |
1 |
0.0001 |
| 73 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 74 |
GLAUCOMA |
1 |
0.0001 |
| 75 |
EAR PAIN |
1 |
0.0001 |
| 76 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 77 |
SKIN CANCER |
1 |
0.0000 |
| 78 |
GLOSSODYNIA |
1 |
0.0000 |
| 79 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 80 |
GAIT DISTURBANCE |
8 |
0.0000 |
| 81 |
PRESYNCOPE |
1 |
0.0000 |
| 82 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 83 |
HOSPITALISATION |
6 |
0.0000 |
| 84 |
DIPLOPIA |
1 |
0.0000 |
| 85 |
DRY MOUTH |
3 |
0.0000 |
| 86 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 87 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 88 |
FEELING COLD |
1 |
0.0000 |
| 89 |
EYE PAIN |
2 |
0.0000 |
| 90 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 91 |
LETHARGY |
2 |
0.0000 |
| 92 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 93 |
OESOPHAGEAL CARCINOMA |
1 |
0.0000 |
| 94 |
HEADACHE |
21 |
0.0000 |
| 95 |
HYPERTENSION |
7 |
0.0000 |
| 96 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 97 |
FATIGUE |
25 |
0.0000 |
| 98 |
PARAESTHESIA |
5 |
0.0000 |
| 99 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 100 |
EYE DISORDER |
1 |
0.0000 |
| 101 |
DIZZINESS |
15 |
0.0000 |
| 102 |
GAIT INABILITY |
1 |
0.0000 |
| 103 |
EYE PRURITUS |
1 |
0.0000 |
| 104 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 105 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 106 |
NIGHTMARE |
1 |
0.0000 |
| 107 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 108 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 109 |
PANIC ATTACK |
1 |
0.0000 |
| 110 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 111 |
HYPOAESTHESIA |
4 |
0.0000 |
| 112 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 113 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 114 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 115 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 116 |
COVID-19 |
4 |
0.0000 |
| 117 |
THROAT IRRITATION |
1 |
0.0000 |
| 118 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 119 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 120 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 121 |
VISION BLURRED |
3 |
0.0000 |
| 122 |
ADVERSE EVENT |
2 |
0.0000 |
| 123 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 124 |
RENAL DISORDER |
1 |
0.0000 |
| 125 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 126 |
CONTUSION |
2 |
0.0000 |
| 127 |
DYSPEPSIA |
2 |
0.0000 |
| 128 |
DRY EYE |
1 |
0.0000 |
| 129 |
AGGRESSION |
1 |
0.0000 |
| 130 |
FLUSHING |
2 |
0.0000 |
| 131 |
ASTHENIA |
7 |
0.0000 |
| 132 |
RASH PRURITIC |
1 |
0.0000 |
| 133 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 134 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 135 |
BONE PAIN |
1 |
0.0000 |
| 136 |
CHILLS |
2 |
0.0000 |
| 137 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 138 |
FEELING ABNORMAL |
4 |
0.0000 |
| 139 |
IRRITABILITY |
1 |
0.0000 |
| 140 |
STOMATITIS |
1 |
0.0000 |
| 141 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 142 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 143 |
HYPERHIDROSIS |
2 |
0.0000 |
| 144 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 145 |
ALOPECIA |
3 |
0.0000 |
| 146 |
FALL |
5 |
0.0000 |
| 147 |
SLEEP DISORDER |
1 |
0.0000 |
| 148 |
EPISTAXIS |
1 |
0.0000 |
| 149 |
HOT FLUSH |
1 |
0.0000 |
| 150 |
ACNE |
1 |
0.0000 |
| 151 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 152 |
BACK PAIN |
3 |
0.0000 |
| 153 |
TREATMENT FAILURE |
1 |
0.0000 |
| 154 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 155 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 156 |
BALANCE DISORDER |
1 |
0.0000 |
| 157 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 158 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 159 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 160 |
CHEST PAIN |
2 |
0.0000 |
| 161 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 162 |
MIGRAINE |
1 |
0.0000 |
| 163 |
NAUSEA |
8 |
0.0000 |
| 164 |
HEART RATE INCREASED |
1 |
0.0000 |
| 165 |
HYPOTENSION |
2 |
0.0000 |
| 166 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 167 |
ILLNESS |
1 |
0.0000 |
| 168 |
INFLUENZA |
1 |
0.0000 |
| 169 |
SEPSIS |
1 |
0.0000 |
| 170 |
DEPRESSION |
2 |
0.0000 |
| 171 |
PALPITATIONS |
1 |
0.0000 |
| 172 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 173 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 174 |
INSOMNIA |
2 |
0.0000 |
| 175 |
COUGH |
2 |
0.0000 |
| 176 |
ANXIETY |
2 |
0.0000 |
| 177 |
INFECTION |
1 |
0.0000 |
| 178 |
OFF LABEL USE |
6 |
0.0000 |
| 179 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 180 |
VOMITING |
3 |
0.0000 |
| 181 |
DRUG INTERACTION |
1 |
0.0000 |
| 182 |
TREMOR |
1 |
0.0000 |
| 183 |
URTICARIA |
1 |
0.0000 |
| 184 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 185 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 186 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 187 |
MUSCLE SPASMS |
1 |
0.0000 |
| 188 |
DRUG INEFFECTIVE |
7 |
0.0000 |
| 189 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 190 |
DYSPNOEA |
3 |
0.0000 |
| 191 |
PRURITUS |
2 |
0.0000 |
| 192 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 193 |
DIARRHOEA |
3 |
0.0000 |
| 194 |
MALAISE |
2 |
0.0000 |
| 195 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 196 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 197 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 198 |
PAIN |
2 |
0.0000 |
| 199 |
ARTHRALGIA |
1 |
0.0000 |
| 200 |
DEATH |
2 |
0.0000 |
| 201 |
RASH |
1 |
0.0000 |